CG-549 Tablet Pharmacokinetics Study
NCT05393856
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
CG-549
Sponsor
CrystalGenomics, Inc.